AKRO logo

Akero Therapeutics (AKRO) Working capital

annual working capital:

$730.63M+$189.79M(+35.09%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AKRO annual working capital is $730.63 million, with the most recent change of +$189.79 million (+35.09%) on December 31, 2024.
  • During the last 3 years, AKRO annual working capital has risen by +$562.17 million (+333.72%).
  • AKRO annual working capital is now at all-time high.

Performance

AKRO Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKRObalance sheet metrics

quarterly working capital:

$670.71M-$59.91M(-8.20%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKRO quarterly working capital is $670.71 million, with the most recent change of -$59.91 million (-8.20%) on March 31, 2025.
  • Over the past year, AKRO quarterly working capital has dropped by -$210.31 million (-23.87%).
  • AKRO quarterly working capital is now -23.87% below its all-time high of $881.02 million, reached on March 31, 2024.

Performance

AKRO quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKRObalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

AKRO Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.1%-23.9%
3 y3 years+333.7%+359.9%
5 y5 years+467.8%+468.7%

AKRO Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+333.7%-23.9%+326.0%
5 y5-yearat high+467.8%-23.9%+552.4%
alltimeall timeat high>+9999.0%-23.9%+882.1%

AKRO Working capital History

DateAnnualQuarterly
Mar 2025
-
$670.71M(-8.2%)
Dec 2024
$730.63M(+35.1%)
$730.63M(+3.8%)
Sep 2024
-
$703.60M(-5.5%)
Jun 2024
-
$744.84M(-15.5%)
Mar 2024
-
$881.02M(+62.9%)
Dec 2023
$540.83M(+60.9%)
$540.83M(-1.2%)
Sep 2023
-
$547.53M(-11.9%)
Jun 2023
-
$621.60M(+87.9%)
Mar 2023
-
$330.81M(-1.6%)
Dec 2022
$336.09M(+99.5%)
$336.09M(-4.7%)
Sep 2022
-
$352.70M(+124.0%)
Jun 2022
-
$157.45M(+8.0%)
Mar 2022
-
$145.84M(-13.4%)
DateAnnualQuarterly
Dec 2021
$168.45M(-34.8%)
$168.45M(-15.0%)
Sep 2021
-
$198.27M(-9.8%)
Jun 2021
-
$219.76M(-10.5%)
Mar 2021
-
$245.64M(-4.9%)
Dec 2020
$258.23M(+100.7%)
$258.23M(-9.7%)
Sep 2020
-
$286.02M(+178.2%)
Jun 2020
-
$102.80M(-12.8%)
Mar 2020
-
$117.93M(-8.4%)
Dec 2019
$128.68M(+72.1%)
$128.68M(-10.2%)
Sep 2019
-
$143.35M(-9.5%)
Jun 2019
-
$158.37M(+131.9%)
Mar 2019
-
$68.30M(-8.7%)
Dec 2018
$74.79M(>+9900.0%)
$74.79M
Dec 2017
$416.00K
-

FAQ

  • What is Akero Therapeutics annual working capital?
  • What is the all time high annual working capital for Akero Therapeutics?
  • What is Akero Therapeutics annual working capital year-on-year change?
  • What is Akero Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Akero Therapeutics?
  • What is Akero Therapeutics quarterly working capital year-on-year change?

What is Akero Therapeutics annual working capital?

The current annual working capital of AKRO is $730.63M

What is the all time high annual working capital for Akero Therapeutics?

Akero Therapeutics all-time high annual working capital is $730.63M

What is Akero Therapeutics annual working capital year-on-year change?

Over the past year, AKRO annual working capital has changed by +$189.79M (+35.09%)

What is Akero Therapeutics quarterly working capital?

The current quarterly working capital of AKRO is $670.71M

What is the all time high quarterly working capital for Akero Therapeutics?

Akero Therapeutics all-time high quarterly working capital is $881.02M

What is Akero Therapeutics quarterly working capital year-on-year change?

Over the past year, AKRO quarterly working capital has changed by -$210.31M (-23.87%)
On this page